The major outcome of this project was the development of a 2011 R&D strategy by the TSGA. This included a list of R&D priorities for 2011, including AGD related research, and a specific list of areas of interest for 2011. Subsequent to this the TSGA received 7 project proposals pertaining to...

Amoebic gill disease (AGD) remains the major disease associated with sea-cage culture of Atlantic salmon in Tasmania. AGD is associated with a Paramoeba species infecting the gills. Current treatment involves multiple freshwater bathes for all fish. This treatment has a significant financial impact...

Amoebic gill disease (AGD) is considered to be the most significant health problem for farmed Atlantic salmon in Tasmania, costing the industry an estimated $15-20 million pa. It is caused by the presence of Neoparamoeba spp. on the gills and if untreated can lead to death. Although some control of...

This project has increased our knowledge of Amoebic Gill Disease, in particular about the pathogen and the dynamics of infection. We have described a new species of neoparamoeba, Neoparamoeba perurans, and showed that it has been consistently associated with AGD worldwide. Stocking...

The outcome of this project is the development, at the request of industry, of a proposal to enhance the genetic gains in the industry selective breeding program for AGD resistance through marker assisted selection. The confidence to proceed with such a proposal is brought about by the extensive...